Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flavonoids in Cancer and Apoptosis
Mariam Abotaleb, Samson Mathews Samuel, Elizabeth Varghese, et al.
Cancers (2018) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 617

Showing 26-50 of 617 citing articles:

Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
Franklyn De Silva, Jane Alcorn
Pharmaceuticals (2019) Vol. 12, Iss. 2, pp. 68-68
Open Access | Times Cited: 133
Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
Qingmei Ye, Kai Liu, Qun Shen, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 123
Anticancer Potential of Lichens’ Secondary Metabolites
Zuzana Solárová, Alena Líšková, Marek Samec, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 87-87
Open Access | Times Cited: 112
Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
Marek Samec, Alena Líšková, Lenka Koklesová, et al.
The EPMA Journal (2020) Vol. 11, Iss. 3, pp. 377-398
Open Access | Times Cited: 112
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
The EPMA Journal (2021) Vol. 12, Iss. 2, pp. 155-176
Open Access | Times Cited: 98
Enhancement of bioavailability and bioactivity of diet-derived flavonoids by application of nanotechnology: a review
Hui Teng, Yimei Zheng, Hui Cao, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 3, pp. 378-393
Closed Access | Times Cited: 95
Citrusfruits and their flavonoids in inflammatory bowel disease: an overview
Laura Musumeci, Alessandro Maugeri, Santa Cirmi, et al.
Natural Product Research (2019) Vol. 34, Iss. 1, pp. 122-136
Closed Access | Times Cited: 92
Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis , through regulating different signaling pathways
Do Luong Huynh, Neelesh Sharma, Amit Kumar Singh, et al.
Chinese Journal of Natural Medicines (2017) Vol. 15, Iss. 1, pp. 15-40
Closed Access | Times Cited: 91
Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents.
Hidetomo Kikuchi, Bo Yuan, Xiaomei Hu, et al.
PubMed (2019) Vol. 9, Iss. 8, pp. 1517-1535
Closed Access | Times Cited: 90
Molecular Targets of Genistein and Its Related Flavonoids to Exert Anticancer Effects
Hee‐Sung Chae, Rong Xu, Jae-Yeon Won, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2420-2420
Open Access | Times Cited: 88
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
Shweta Devi, Vijay Kumar, Sandeep Kumar Singh, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 99-99
Open Access | Times Cited: 86
Naringenin exerts anticancer effects by inducing tumor cell death and inhibiting angiogenesis in malignant melanoma
Jawun Choi, Dae-Hyo Lee, Hyuk Jang, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 18, pp. 3049-3057
Open Access | Times Cited: 85
A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies
Maryam Ghanbari-Movahed, Gloria Jackson, Mohammad Hosein Farzaei, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 85
Dietary Phytochemicals Targeting Cancer Stem Cells
Alena Líšková, Peter Kubatka, Marek Samec, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 899-899
Open Access | Times Cited: 83
Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
Lenka Koklesová, Alena Líšková, Marek Samec, et al.
The EPMA Journal (2020) Vol. 11, Iss. 2, pp. 261-287
Open Access | Times Cited: 79
Lead bioactive compounds of Aloe vera as potential anticancer agent
Ranabir Majumder, Chandan Kanta Das, Mahitosh Mandal
Pharmacological Research (2019) Vol. 148, pp. 104416-104416
Closed Access | Times Cited: 77
Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers
Milad Ashrafizadeh, Ali Zarrabi, Maryam Hashemipour, et al.
Pharmacological Research (2020) Vol. 160, pp. 105199-105199
Closed Access | Times Cited: 75
Role of Flavonoids in the Treatment of Iron Overload
Xiaomin Wang, Ye Li, Han Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 74
Proanthocyanidins: Components, Pharmacokinetics and Biomedical Properties
Yanxi Zeng, Sen Wang, Lu Wei, et al.
The American Journal of Chinese Medicine (2020) Vol. 48, Iss. 04, pp. 813-869
Closed Access | Times Cited: 71
Metabolic engineering and synthetic biology of plant natural products – A minireview
Aaron S. Birchfield, Cecilia A. McIntosh
Current Plant Biology (2020) Vol. 24, pp. 100163-100163
Open Access | Times Cited: 71
Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders
Marco Emili, Sandra Guidi, Beatrice Uguagliati, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 62, Iss. 1, pp. 13-50
Open Access | Times Cited: 70
Vascular disrupting agents in cancer therapy
Ryszard Smolarczyk, Justyna Czapla, Magdalena Jarosz‐Biej, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173692-173692
Closed Access | Times Cited: 70
Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
Peter Kubatka, Alena Mazuráková, Marek Samec, et al.
The EPMA Journal (2021) Vol. 12, Iss. 4, pp. 559-587
Open Access | Times Cited: 64
AhR and Cancer: From Gene Profiling to Targeted Therapy
Anaïs Paris, Nina Tardif, Marie‐Dominique Galibert, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 752-752
Open Access | Times Cited: 61
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Aranka Brockmueller, Saba Sameri, Alena Líšková, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 188-188
Open Access | Times Cited: 60

Scroll to top